Mimpara Granules
*Company:
Amgen Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 03 February 2023
File name
en_mimpara_capsules_approved_spc_v65.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 11 January 2022
File name
en_mimpara_ capsules_approved_pil_v71 XI and IE.pdf
Reasons for updating
- Change to MA holder contact details
Free text change information supplied by the pharmaceutical company
QRD v10.2
Updated on 27 February 2020
File name
en_mimpara_capsules_approved_spc_v65.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.1 - List of excipients
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 27 February 2020
File name
en_mimpara_ capsules_approved_pil_v65.pdf
Reasons for updating
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 27 August 2019
File name
en_mimpara capsules_approved_PIL_v55.pdf
Reasons for updating
- New PIL for new product
Updated on 27 August 2019
File name
en_mimpara_spc_capsules_v62_.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)